Dialysis-from-home: meet the company that's revolutionizing renal?care

U.K-based medical device company Quanta Dialysis Technologies (QDT) has developed a portable dialysis machine that can seamlessly integrate in home or hospital settings, effectively removing acessiblity barriers from hemodialysis treatment processses. According to the National Kidney Foundation, about 10% of the world’s population suffer from Chronic Kidney Disease (CKD) and millions lose their lives because of lack of affordable treatment options.

If you perform dialysis slower, more often, overnight, patients are getting better outcomes

- Dr. Paul Komenda, CMO of Quanta Dialysis Technologies

QDT’s flagship SC+ hemodialysis system weighs in at only 71 lbs - a fraction of the weight of their competitors’ product. With an impressive leadership team boasting of former corporate heavyweights and seasoned medical professionals, QDT hopes to make dialysis treatment accessible to “every patient in every setting”. As opposed to traditional dilaysis machines which are large and require complex operational setup along with expensive upkeep, the SC+ system is simple to use and can be used at home while the patient sleeps, eliminating stressful appointments and yielding better results.?

“Most dialysis in the world is provided with large refrigirator style hemodialysis devices, and it has terrible outcomes for patients - about 5% mortality in 5 years, and its very costly to do it. If you perform dialysis slower, more often, overnight, patients are getting better outcomes.” said Dr. Paul Komenda, Chief Medical Officer of QDT in a recent interview with How It’s Med. He further described his journey from a medical researcher to the health tech industry, highlighting the importance of innovation to ensure a better future for healthcare.

Dr Paul Komenda is a Professor of Medicine at the University of Manitoba, a fellow of the American Society of Nephrology and has extensive clinical and academic experience. Prior to joining Quanta, Dr Komenda served on the Scientific Advisory Board of NxStage Medical.

In July 2021, QDT raised $245 million in an a Series D round, making it the recipient of the largest private fund by a dialysis device company in history. The SC+ device is commercially available in the U.K and is FDA approved for use in the U.S.

How It’s Med is a medical technology-focused media company that brings you the latest new in the world of health technology. Through its collaborations with Health Canada Infoway and Macadamian Technologies, How It's Med aims to simplify the process of learning about and contributing to the advancement of healthcare.